Works matching IS 08991987 AND DT 2019 AND VI 58 AND IP 6

Results: 23

Issue Information ‐ Ed Board.

Published in:: Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 833, doi. 10.1002/mc.23040
Publication type:: Article

AKT‐dependent sugar addiction by benzyl isothiocyanate in breast cancer cells.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 996, doi. 10.1002/mc.22988

By:

Roy, Ruchi;
Hahm, Eun‐Ryeong;
White, Alexander G.;
Anderson, Carolyn J.;
Singh, Shivendra V.

Publication type:

Article

Neuroplastin‐β mediates S100A8/A9‐induced lung cancer disseminative progression.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 980, doi. 10.1002/mc.22987

By:

Sumardika, I Wayan;
Chen, Youyi;
Tomonobu, Nahoko;
Kinoshita, Rie;
Ruma, I Made Winarsa;
Sato, Hiroki;
Kondo, Eisaku;
Inoue, Yusuke;
Yamauchi, Akira;
Murata, Hitoshi;
Yamamoto, Ken‐ichi;
Tomida, Shuta;
Shien, Kazuhiko;
Yamamoto, Hiromasa;
Soh, Junichi;
Futami, Junichiro;
Putranto, Endy Widya;
Hibino, Toshihiko;
Nishibori, Masahiro;
Toyooka, Shinichi

Publication type:

Article

Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 837, doi. 10.1002/mc.22986

By:

Eckert, Richard L.

Publication type:

Article

Issue Information ‐ TOC.

Published in:: Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 834, doi. 10.1002/mc.23039
Publication type:: Article

EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β‐catenin pathway.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 967, doi. 10.1002/mc.22985

By:

Zhang, Qing‐Wei;
Zhang, Xin‐Tian;
Tang, Chao‐Tao;
Lin, Xiao‐Lu;
Ge, Zhi‐Zheng;
Li, Xiao‐Bo

Publication type:

Article

Receptor tyrosine kinase recepteur d'origine nantais as predictive marker for aggressive prostate cancer in African Americans.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 854, doi. 10.1002/mc.23002

By:

Bedolla, Roble G.;
Shah, Dimpy P.;
Huang, Shih‐Bo;
Reddick, Robert L.;
Ghosh, Rita;
Kumar, Addanki P.

Publication type:

Article

ETS1 is coexpressed with ZEB2 and mediates ZEB2‐induced epithelial‐mesenchymal transition in human tumors.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 1068, doi. 10.1002/mc.22994

By:

Yalim‐Camci, Irem;
Balcik‐Ercin, Pelin;
Cetin, Metin;
Odabas, Gorkem;
Tokay, Nurettin;
Sayan, A. Emre;
Yagci, Tamer

Publication type:

Article

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 1056, doi. 10.1002/mc.22993

By:

Zhao, Zhenjiang;
Jin, Guoguo;
Yao, Ke;
Liu, Kangdong;
Liu, Fangfang;
Chen, Hanyong;
Wang, Keke;
Gorja, Dhilli Rao;
Reddy, Kanamata;
Bode, Ann M.;
Guo, Zhiping;
Dong, Zigang

Publication type:

Article

Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non–small‐cell lung cancer cells.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 1046, doi. 10.1002/mc.22992

By:

Chen, Wenshu;
Do, Kieu C.;
Saxton, Bryanna;
Leng, Shuguang;
Filipczak, Piotr;
Tessema, Mathewos;
Belinsky, Steven A.;
Lin, Yong

Publication type:

Article

Antitumor Effect of Periplocin in TRAIL‐Resistant gastric cancer cells via upregulation of death receptor through activating ERK1/2‐EGR1 pathway.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 1033, doi. 10.1002/mc.22991

By:

Zhao, Lian‐Mei;
Li, Lei;
Huang, Ying;
Han, Lu‐juan;
Li, Dan;
Huo, Bing‐Jie;
Dai, Su‐li;
Xu, Li‐yan;
Zhan, Qimin;
Shan, Bao‐En

Publication type:

Article

Alteration of the tumor suppressor SARDH in sporadic colorectal cancer: A functional and transcriptome profiling‐based study.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 957, doi. 10.1002/mc.22984

By:

He, Hongjuan;
Chen, Erfei;
Lei, Lei;
Yan, Bianbian;
Zhao, Xiaojuan;
Zhu, Ziqing;
Li, Qiqi;
Zhang, Pan;
Zhang, Wei;
Xing, Jinliang;
Du, Le;
Dong, Jing;
Yang, Jin

Publication type:

Article

The regulation of Neuropilin 1 expression by miR‐338‐3p promotes non‐small cell lung cancer via changes in EGFR signaling.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 1019, doi. 10.1002/mc.22990

By:

Ding, Zongli;
Zhu, Jianjie;
Zeng, Yuanyuan;
Du, Wenwen;
Zhang, Yang;
Tang, Haicheng;
Zheng, Yulong;
Qin, Hualong;
Liu, Zeyi;
Huang, Jian‐an

Publication type:

Article

Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β‐catenin signaling pathway.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 1008, doi. 10.1002/mc.22989

By:

Zhang, Xiaoli;
Liu, Ruihua;
Zhao, Na;
Ji, Shufang;
Hao, Chunyan;
Cui, Weiwei;
Zhang, Ruihong;
Hao, Jing

Publication type:

Article

The HDAC6‐selective inhibitor is effective against non‐Hodgkin lymphoma and synergizes with ibrutinib in follicular lymphoma.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 944, doi. 10.1002/mc.22983

By:

Lee, Dong Hoon;
Kim, Go Woon;
Kwon, So Hee

Publication type:

Article

Non‐coding and coding genomic variants distinguish prostate cancer, castration‐resistant prostate cancer, familial prostate cancer, and metastatic castration‐resistant prostate cancer from each other.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 862, doi. 10.1002/mc.22975

By:

Alanazi, Ibrahim O.;
Al Shehri, Zafer S.;
Ebrahimie, Esmaeil;
Giahi, Hassan;
Mohammadi‐Dehcheshmeh, Manijeh

Publication type:

Article

Cover Picture: Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy target (Mol Carcinog 6/2019).

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. i, doi. 10.1002/mc.22859

By:

Eckert, Richard L.

Publication type:

Article

NEK5 promotes breast cancer cell proliferation through up‐regulation of Cyclin A2.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 933, doi. 10.1002/mc.22982

By:

Pei, Jing;
Zhang, Jing;
Yang, Xiaowei;
Wu, Zhengsheng;
Sun, Chenyu;
Wang, Zhaorui;
Wang, Benzhong

Publication type:

Article

MIF promotes perineural invasion through EMT in salivary adenoid cystic carcinoma.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 898, doi. 10.1002/mc.22979

By:

Zhang, Mei;
Li, Zhu‐feng;
Wang, Hao‐fan;
Wang, Sha‐sha;
Yu, Xiang‐hua;
Wu, Jing‐biao;
Pang, Xin;
Wu, Jia‐shun;
Yang, Xiao;
Tang, Ya‐jie;
Li, Li;
Liang, Xin‐hua;
Zheng, Min;
Tang, Ya‐ling

Publication type:

Article

Epigenetic regulation of the human ATP2A3 gene promoter in gastric and colon cancer cell lines.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 887, doi. 10.1002/mc.22978

By:

Meneses‐Morales, Iván;
Izquierdo‐Torres, Eduardo;
Flores‐Peredo, Lucía;
Rodríguez, Gabriela;
Hernández‐Oliveras, Andrés;
Zarain‐Herzberg, Ángel

Publication type:

Article

Antitumor effects of circ‐EPHB4 in hepatocellular carcinoma via inhibition of HIF‐1α.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 875, doi. 10.1002/mc.22976

By:

Tan, Yuhui;
Du, Biaoyan;
Zhan, Yujuan;
Wang, Kun;
Wang, Xiaolan;
Chen, Bonan;
Wei, Xianli;
Xiao, Jianyong

Publication type:

Article

Identification of epithelial‐specific ETS‐1 (ESE‐1) as a tumor suppressor and molecular target of green tea compound, EGCG.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 922, doi. 10.1002/mc.22981

By:

Ha, Taekyu;
Lee, Jihye;
Lou, Zhiyuan;
Lee, Bok‐Soon;
Kim, Chul‐Ho;
Lee, Seong‐Ho

Publication type:

Article

Functional polymorphisms on chromosome 5p15.33 disturb telomere biology and confer the risk of non‐small cell lung cancer in Chinese population.

Published in:

Molecular Carcinogenesis, 2019, v. 58, n. 6, p. 913, doi. 10.1002/mc.22980

By:

Li, Ying;
Xiang, Cheng;
Shen, Na;
Deng, Lingyan;
Luo, Xia;
Yuan, Peihong;
Ji, Zhi;
Li, Jiaoyuan;
Cheng, Liming

Publication type:

Article